Silo Pharma’s QwikAgents Partners with AMD AI Developer Program
Event summary
- QwikAgents, a subsidiary of Silo Pharma, has joined the AMD AI Developer Program.
- The program provides access to AMD’s developer cloud credits, AI tools, training resources, and a global community.
- QwikAgents aims to accelerate development, testing, optimization, and deployment of its enterprise AI agent platform.
- Starter plans for QwikAgents begin at $14 per month with scalable infrastructure options.
The big picture
Silo Pharma’s move to integrate with AMD’s AI Developer Program underscores the growing trend of biotech firms leveraging advanced AI infrastructure to enhance their digital capabilities. This partnership could position QwikAgents as a competitive player in the enterprise AI agent space, particularly for use cases like research, content generation, and workflow automation.
What we're watching
- Platform Scalability
- How QwikAgents leverages AMD’s resources to enhance platform performance and reliability.
- Market Adoption
- Whether QwikAgents can attract enterprises, developers, and small businesses with its affordable AI agent tools.
- Competitive Positioning
- The pace at which QwikAgents differentiates itself in the crowded AI agent market.
Related topics